First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension

NCT01247116 · clinicaltrials.gov ↗
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Calgary

Collaborators